Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit

Journal of Medical Microbiology

Volumn 55, Issue 10, 2006, Pages 1435-1439

  Horianopoulou, Maria ^a   Legakis, Nicholas J ^b   Kanellopoulou, Maria ^a   Lambropoulos, Sotiris ^a   Tsakris, Athanassios ^b   Falagas, Matthew E ^c,d  

^a SISMANOGLIO HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM DERIVATIVE; CARBAPENEM DERIVATIVE; METALLO BETA LACTAMASE; PROTEIN VIM 2; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLA GENE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER AEROGENES; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT INFECTION; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; STENOTROPHOMONAS MALTOPHILIA; TERTIARY HEALTH CARE; TRACHEOBRONCHIAL TREE;

ACUTE DISEASE; BETA-LACTAMASES; BETA-LACTAMS; BRONCHI; CARBAPENEMS; CARRIER STATE; CROSS INFECTION; FEMALE; GENES, BACTERIAL; GRAM-NEGATIVE BACTERIA; GREECE; HOSPITALS, GENERAL; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; TIME FACTORS; TRACHEA; URBAN POPULATION;

EID: 33750433547     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46713-0     Document Type: Article

References (22)

1. Andrade, S. S., Jones, R. N., Gales, A. C. & Sader, H. S. (2003). Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother 52, 140-141.
2. Bonten, M. J. & Weinstein, R. A. (1996). The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol 17, 193-200.
3. Bonten, M. J., Gaillard, C. A., van Tiel, F. H., Smeets, H. G., van der Geest, S. & Stobberingh, E. E. (1994). The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients. Chest 105, 878-884.
4. de Champs, C., Poirel, L., Bonnet, R., Sirot, D., Chanal, C., Sirot, J. & Nordmann, P. (2002). Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 46, 3031-3034.
5. Flaherty, J. P. & Weinstein, R. A. (1996). Nosocomial infection caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 17, 236-248.
6. Itokazu, G. S., Quinn, J. P., Bell-Dixon, C., Kahan, F. M. & Weinstein, R. A. (1996). Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 23, 779-784.
7. Jarvis, W. R. (1996). The epidemiology of colonization. Infect Control Hosp Epidemiol 17, 47-52.
8. Jarvis, W. R., Edwards, J. R., Culver, D. H. & 8 other authors (1991). Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 91 (Suppl. 2), S185-S191.
9. Johanson, W. G., Jr, Pierce, A. K., Sanford, J. P. & Thomas, G. D. (1972). Nosocomial respiratory infections with Gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 77, 701-706.
10. Kerver, A. J., Rommes, J. H., Mevissen-Verhage, E. A., Hulstaert, P. F., Vos, A., Verhoef, J. & Wittebol, P. (1988). Prevention of colonization and infection in critically ill patients: a prospective randomized study. Crit Care Med 16, 1087-1093.
11. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43, 1584-1590.
12. Le Gall, J. R., Lemeshow, S. & Saulnier, F. (1993). A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (J Am Med Assoc) 270, 2957-2963.
13. Mavroidi, A., Tsakris, A., Tzelepi, E., Pournaras, S., Loukova, V. & Tzouvelekis, L. S. (2000). Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. J Antimicrob Chemother 46, 1041-1042.
14. Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D. & Nordmann, P. (2000). Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44, 891-897.
15. VIM-1 in a clinical strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother 46, 4026-4028.
16. VIM-4. J Antimicrob Chemother 51, 1409-1414.
17. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams. J Clin Microbiol 34, 2909-2913.
18. Trautmann, M., Michalsky, T., Wiedeck, H., Radosavljevic, V. & Ruhnke, M. (2001). Tap water colonization with Pseudomonas aeruginosa in a surgical intensive care unit (ICU) and relation to Pseudomonas infections of ICU patients. Infect Control Hosp Epidemiol 22, 49-52.
19. Tsakris, A., Pournaras, S., Woodford, N., Palepou, M.-F. I., Babini, G. S., Douboyas, J. & Livermore, D. M. (2000). Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 38, 1290-1292.
20. Walsh, T. R., Toleman, M. A., Poirel, L. & Nordmann, P. (2005). Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 18, 306-325.
21. Woods, D. E., Straus, D. C., Johanson, W. G., Jr & Bass, J. A. (1981). Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells. J Infect Dis 143, 784-790.
22. Yan, J.-J., Hsueh, P.-R., Ko, W.-C., Luh, K.-T., Tsai, S.-H., Wu, H.-M. & Wu, J. J. (2001). Metallo-β ± -lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 45, 2224-2228.